These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10226868)

  • 1. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
    Os I; Stokke HP
    J Cardiovasc Pharmacol; 1999 May; 33(5):791-7. PubMed ID: 10226868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension.
    Os I; Stokke HP
    Blood Press; 1999; 8(3):184-91. PubMed ID: 10595697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.
    Andersen M; Dahlstrand C; Høye K
    Eur Urol; 2000 Oct; 38(4):400-9. PubMed ID: 11025377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of doxazosin GITS and standard doxazosin in the treatment of high blood pressure.
    Os I
    Int J Clin Pharmacol Ther; 2006 Mar; 44(3):99-106. PubMed ID: 16550731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of doxazosin GITS on blood pressure in hypertensive and normotensive patients: a review of hypertension and BPH studies.
    Lund-Johansen P; Kirby RS
    Blood Press Suppl; 2003 May; 1():5-13. PubMed ID: 12800982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension.
    Anegón M; Esteban J; Jiménez-García R; Sanz de Burgoa V; Martínez J; Gil de Miguel A
    Clin Ther; 2002 May; 24(5):786-97. PubMed ID: 12075946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
    Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B
    Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia.
    Kirby RS; Andersen M; Gratzke P; Dahlstrand C; Høye K
    BJU Int; 2001 Feb; 87(3):192-200. PubMed ID: 11167641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
    Gratzke P; Kirby RS
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
    de Alvaro F; Hernández-Presa MA;
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled-release doxazosin as combination therapy in hypertension: the GATES study.
    Black HR; Keck M; Meredith P; Bullen K; Quinn S; Koren A
    J Clin Hypertens (Greenwich); 2006 Mar; 8(3):159-66; quiz 167-8. PubMed ID: 16522992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.
    Chung M; Vashi V; Puente J; Sweeney M; Meredith P
    Br J Clin Pharmacol; 1999 Nov; 48(5):678-87. PubMed ID: 10594469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: a randomized, placebo-controlled study.
    Black HR; Sollins JS; Garofalo JL
    Am J Hypertens; 2000 May; 13(5 Pt 1):468-74. PubMed ID: 10826396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia.
    Goldsmith DR; Plosker GL
    Drugs; 2005; 65(14):2037-47. PubMed ID: 16162024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
    Toal CB
    Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; Domínguez MJ; Covelo M; Fernández JR; Fontao MJ; López JE
    Chronobiol Int; 2004 Mar; 21(2):277-96. PubMed ID: 15332347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical ease of using doxazosin in BPH patients with and without hypertension.
    Steers WD; Kirby RS
    Prostate Cancer Prostatic Dis; 2005; 8(2):152-7. PubMed ID: 15711605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
    Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
    Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension.
    Lemmer B; Nold G
    Blood Press Monit; 2003 Jun; 8(3):119-25. PubMed ID: 12900589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia.
    Kirby RS
    BJU Int; 2003 Jan; 91(1):41-4. PubMed ID: 12614248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.